The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 128K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fong, A. M.
Right arrow Articles by Patel, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fong, A. M.
Right arrow Articles by Patel, D. D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1998/10/1413/ $5.00
The Journal of Experimental Medicine, Volume 188, Number 8, October 19, 1998 1413-1419


Articles

Fractalkine and CX3CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic Flow

Alan M. Fong*, Lisa A. Robinson{ddagger},§, Douglas A. Steeber{ddagger}, Thomas F. Tedder{ddagger}, Osamu Yoshie||, Toshio Imai||, and Dhavalkumar D. Patel*,{ddagger}

From the * Department of Medicine, the {ddagger} Department of Immunology, and the § Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710; and the || Shionogi Institute for Medical Science, Settsu 566, Japan

Leukocyte migration into sites of inflammation involves multiple molecular interactions between leukocytes and vascular endothelial cells, mediating sequential leukocyte capture, rolling, and firm adhesion. In this study, we tested the role of molecular interactions between fractalkine (FKN), a transmembrane mucin-chemokine hybrid molecule expressed on activated endothelium, and its receptor (CX3CR1) in leukocyte capture, firm adhesion, and activation under physiologic flow conditions. Immobilized FKN fusion proteins captured resting peripheral blood mononuclear cells at physiologic wall shear stresses and induced firm adhesion of resting monocytes, resting and interleukin (IL)-2–activated CD8+ T lymphocytes and IL-2–activated NK cells. FKN also induced cell shape change in firmly adherent monocytes and IL-2–activated lymphocytes. CX3CR1-transfected K562 cells, but not control K562 cells, firmly adhered to FKN-expressing ECV-304 cells (ECV-FKN) and tumor necrosis factor {alpha}–activated human umbilical vein endothelial cells. This firm adhesion was not inhibited by pertussis toxin, EDTA/EGTA, or antiintegrin antibodies, indicating that the firm adhesion was integrin independent. In summary, FKN mediated the rapid capture, integrin-independent firm adhesion, and activation of circulating leukocytes under flow. Thus, FKN and CX3CR1 mediate a novel pathway for leukocyte trafficking.

Key Words: leukocyte migration • chemokines • cell adhesion • fractalkine • chemokine receptors


Address correspondence to Dhavalkumar D. Patel, Box 3258, 222 CARL Bldg., Duke University Medical Center, Durham, NC 27710. Phone: 919-684-4234; Fax: 919-684-5230; E-mail: patel003{at}mc.duke.edu

A.M. Fong and L.A. Robinson contributed equally to this work.

Abbreviations used: ELC, EBI1 ligand chemokine; FKN, fractalkine; HUVECs, human umbilical vein endothelial cells; IF, immunofluorescence; MCP, monocyte chemotactic protein; PTX, pertussis toxin; SEAP, secreted placental alkaline phosphatase; TARC, thymus and activation regulated chemokine.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS